#Biotech #Immunotherapy #ImmunoOncology #Cancer #Inflammation #Antibody #Checkpoints" title="" class="btn" data-container="body" data-html="true" data-id="93995" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="Innate Pharma"> 4,094 27,354
Activities
Technologies
Entity types
Location
117 Av. de Luminy, 13009 Marseille, France
Marseille
France
Employees
Scale: 201-500
Estimated: 196
SIREN
424365336Engaged catalyst
26Added in Motherbase
5 years, 2 months agoInnate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.
Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.
Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.
biotechnologies, antibodies, immunotherapy, and oncology
Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.
Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.
Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.
Catalyst | Type | Tweets | Articles | |
---|---|---|---|---|
![]() La Tribune Media, Newspapers | La Tribune Media, Newspapers | Other 22 May 2023 | | |
![]() BFM Business Media, Broadcast Media Production and Distribution | BFM Business Media, Broadcast Media Production and Distribution | Other 15 Dec 2021 25 Nov 2023 | | |
![]() Le Journal des Entreprises Media, Newspaper Publishing | Le Journal des Entreprises Media, Newspaper Publishing | Not capitalistic Partnership Not event 15 Nov 2024 | | |
![]() Bpifrance Bank, Banking | Bpifrance Bank, Banking | Not capitalistic Partnership Event 11 Aug 2020 | | |
![]() La French Tech Media, Government Administration | La French Tech Media, Government Administration | Not capitalistic Partnership Event 7 Jun 2016 | | |
![]() Grand Luminy Technopole Business Consulting and Services | Grand Luminy Technopole Business Consulting and Services | Not capitalistic Not partnership Event 3 Dec 2020 12 Nov 2024 | | |